Published on 29 Jan 2025 on Benzinga
Robert F. Kennedy Jr., President Donald Trump's pick for health secretary, addressed a wide range of medical-related topics on Wednesday during a confirmation hearing with the Senate Finance Committee.
While Kennedy’s tone in each back-and-forth varied, depending on the senator, it was evident that Kennedy’s role in the new administration would have a tremendous impact on both pharma and insurance stocks.